|

CX-2051 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • CytomX Therapeutics1

Indications

  • Solid Tumor, Adult1
  • Cancer1

Denver, Colorado1 trial

First In Human Study of CX-2051 in Advanced Solid Tumors

Sarah Cannon Research Institute at HealthONE

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.